HebeCell
PrivateLast Round
Series A
Aug 31, 2021
Est. Valuation
$152.44M
Total Funding Raised
$68M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HebeCell is a biotechnology company that develops cell-based therapeutics and manufacturing platforms for immuno-oncology and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Freemium
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HebeCell Comparables
Compare HebeCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 86% | |
| Century Therapeutics | 80% | |
| Artiva | 79% |
HebeCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 31, 2021 | ||||
| Pre Seed | Apr 24, 2020 |
HebeCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Falcon Creek Capital | Series A |
| Fangyuan Capital (Hong Kong) Limited | Series A |
| Plaisance Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 51% MoM, from 806 to 1.2K.
- Jul 26, 2026
Monthly visitors increased 107% MoM, reaching 806.
HebeCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HebeCell's valuation, stock price, and market status.
Is HebeCell a public or private company?
HebeCell is a private company.
What is the current stock price of HebeCell?
HebeCell is a private company with no public stock price. No recent secondary market data is available.
How much is HebeCell worth (valuation)?
HebeCell's valuation is estimated at $126.7M based on funding round data.
Can I buy HebeCell stock?
HebeCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HebeCell's last funding round?
HebeCell's most recent funding round was Series A on August 31, 2021.
Who are the main investors in HebeCell?
Key investors in HebeCell include Falcon Creek Capital.
Will HebeCell IPO soon?
No public IPO plans have been announced for HebeCell.
How can I track HebeCell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HebeCell's secondary market activity and sign up for updates.